BE861721A - Nouveaux derives de cephalosporine, procedes pour les preparer et medicaments en contenant - Google Patents

Nouveaux derives de cephalosporine, procedes pour les preparer et medicaments en contenant

Info

Publication number
BE861721A
BE861721A BE183351A BE183351A BE861721A BE 861721 A BE861721 A BE 861721A BE 183351 A BE183351 A BE 183351A BE 183351 A BE183351 A BE 183351A BE 861721 A BE861721 A BE 861721A
Authority
BE
Belgium
Prior art keywords
preparing
methods
products containing
medicinal products
cephalosporin derivatives
Prior art date
Application number
BE183351A
Other languages
English (en)
Inventor
E Kiesewetter
H Muckter
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of BE861721A publication Critical patent/BE861721A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/48Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical
    • C07D499/58Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical
    • C07D499/62Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by sulfur atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE183351A 1976-12-10 1977-12-09 Nouveaux derives de cephalosporine, procedes pour les preparer et medicaments en contenant BE861721A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762655949 DE2655949A1 (de) 1976-12-10 1976-12-10 Neue cephalosporin- und penicillinderivate, verfahren zu deren herstellung und diese produkte enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
BE861721A true BE861721A (fr) 1978-03-31

Family

ID=5995155

Family Applications (1)

Application Number Title Priority Date Filing Date
BE183351A BE861721A (fr) 1976-12-10 1977-12-09 Nouveaux derives de cephalosporine, procedes pour les preparer et medicaments en contenant

Country Status (7)

Country Link
US (1) US4159327A (fr)
JP (1) JPS5373595A (fr)
BE (1) BE861721A (fr)
DE (1) DE2655949A1 (fr)
FR (1) FR2378787A1 (fr)
GB (1) GB1560326A (fr)
NL (1) NL7713290A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322347A (en) * 1978-04-03 1982-03-30 Bristol-Myers Company 2-Carbamoyloxymethyl-penicillin derivatives

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH557381A (de) * 1967-04-15 1974-12-31 Fujisawa Pharmaceutical Co Verfahren zur herstellung von (delta)3-cephemverbindungen.
US3422100A (en) * 1967-05-02 1969-01-14 Bristol Myers Co S-substituted-thioacetamido-cephalosporins
US3948906A (en) * 1967-08-21 1976-04-06 Glaxo Laboratories Limited Cephalosporin compounds
US3922268A (en) * 1969-12-08 1975-11-25 Lilly Co Eli 3-Halomethyl-{66 {hu 3-Cephalosporin esters
GB1478055A (en) * 1973-07-27 1977-06-29 Erba Carlo Spa Cephalosporin compounds
AR207960A1 (es) * 1973-10-03 1976-11-22 Fujisawa Pharmaceutical Co Procedimiento para preparar un acido 7-(acetamido-2-sustituido)-3-cefem-4-carboxilico y sus sales
US4042585A (en) * 1976-03-22 1977-08-16 Eli Lilly And Company Process for preparation of 3-halomethylcephems

Also Published As

Publication number Publication date
DE2655949A1 (de) 1978-06-15
JPS5373595A (en) 1978-06-30
NL7713290A (nl) 1978-06-13
FR2378787A1 (fr) 1978-08-25
GB1560326A (en) 1980-02-06
US4159327A (en) 1979-06-26
FR2378787B1 (fr) 1981-07-24

Similar Documents

Publication Publication Date Title
MC1491A1 (fr) Nouveaux composes bicycliques,procedes pour les preparer et formules pharmaceutiques contenant ces composes
FR2335226A1 (fr) Nouvelles pyrazinecarboxamides utiles comme medicaments et procedes permettant de les preparer
FR2343731A1 (fr) Nouveaux aminoalcoylheterocycles, procedes pour leur preparation et leur utilisation en tant que medicaments
BE799001A (fr) Nouvelles benzodiazepines et procedes pour les preparer
BE859415A (fr) Nouveaux 1-aryloxy-2-hydroxy-3-alcoyleneaminopropanes procedes pour leur preparation et medicaments les renfermant
FR2445319B1 (fr) Derives de pyridine, procedes pour leur preparation et compositions pharmaceutiques les contenant
BE829758A (fr) Nouveaux derives de cephalosporine, leur procede de preparation et medicaments les contenant
BE893378A (fr) Derives de carboximide, procedes pour leur preparation et medicament les contenant
FR2305181A1 (fr) Derives de nitrofurylpyrazole, procedes pour leur preparation et medicaments contenant ces composes
FR2297037A1 (fr) Nouveaux derives de biphenyloxy, medicaments les contenant et procede pour leur preparation
FR2346324A1 (fr) Nouvelles amidino-urees, procede pour leur preparation et medicaments les renfermant
BE829327A (fr) Nouvelles pyridorenzepimunes, procedes pour les preparer et medicaments les contenant
FR2299026A1 (fr) Zhiourees et thiocarbamates, procede pour les preparer et compositions pharmaceutiques les contenant
BE857289A (fr) 2-benzyl-pyrrolidines, procede pour leur preparation et medicaments contenant ces composes
BE842118A (fr) Nouvelles propargyl-2-phenylamino-imidazolines-(2), leurs sels d'addition avec des acides, les medicaments les renfermant et procedes pour leur preparation
FR2290897A1 (fr) Nouveaux derives d'aminopropanol, leur procede de preparation et des medicaments les contenant
FR2292477A1 (fr) Derives de 1-amidoalkyl-4-sulfonyl-piperazine, leur procede d'obtention et medicaments contenant lesdits derives
FR2556725B1 (fr) Derives de 4,5,6,7-tetrahydrothiazolo (5,4-c) pyridine, procedes pour les preparer et medicament les contenant
FR2290212A1 (fr) Nouveaux derives de cephalosporine, leur procede de preparation et composition pharmaceutique les contenant
BE861721A (fr) Nouveaux derives de cephalosporine, procedes pour les preparer et medicaments en contenant
BE848909A (fr) Nouvelles isothiourees, procede pour les preparer et compositions pharmaceutiques les contenant
BE829071A (fr) 4-aryl-5-amindalkyl-4-thiazoline-2-ones, derives et procedes pour les preparer
BE853444A (fr) Derives dipeptidiques, procedes pour les preparer et compositions pharmaceutiques en contenant
FR2338250A1 (fr) Mono-insuline, procede pour la preparer et medicaments la contenant
BE863588A (fr) Nouveaux 1,1-dioxydes de 2,5-dihydro-1,2-thiazino (5,6-)indole-3-carboxamides,procedes pour leur preparation et medicaments les renfermant